====== ABT-702 5μM plus CoCl2 18μM R07 exp320 ====== ==== Mechanism of Action ==== Inhibits adenosine kinase (ADK) * **Class / Subclass 1:** Metabolism / Metabolic Enzyme Inhibitor ==== Technical Notes ==== === ABT-702 === * **PubChem Name:** %%Adenosine Kinase Inhibitor%% * **Synonyms:** N/A * **CAS #:** 1188890-28-9 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/16760265|16760265]] * **IUPAC:** %%5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-amine;dihydrochloride%% * **INCHI Name:** InChI=1S/C22H19BrN6O.2ClH/c23-16-3-1-2-14(10-16)17-11-18(28-22-20(17)21(24)26-13-27-22)15-4-5-19(25-12-15)29-6-8-30-9-7-29;;/h1-5,10-13H,6-9H2,(H2,24,26,27,28);2*1H * **INCHI Key:** OOXNYFKPOPJIOT-UHFFFAOYSA-N * **Molecular Weight:** 536.2 * **Canonical SMILES:** C1COCCN1C2=NC=C(C=C2)C3=NC4=NC=NC(=C4C(=C3)C5=CC(=CC=C5)Br)N.Cl.Cl * **Isomeric SMILES:** N/A * **Molecular Formula:** C22H21BrCl2N6O {{:chemogenomics:structures:chem-0155.svg?nolink}} * **Supplier Name:** Tocris Bioscience * **Catalog #:** 2372 * **Lot #:** 1B/195137 * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C22H19BrN6O 463.08765; found 463.08744 === CoCl2 === * **PubChem Name:** %%Cobalt dichloride hexahydrate%% * **Synonyms:** N/A * **CAS #:** 7791-13-1 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/24643|24643]] * **IUPAC:** %%cobalt(2+);dichloride;hexahydrate%% * **INCHI Name:** InChI=1S/2ClH.Co.6H2O/h2*1H;;6*1H2/q;;+2;;;;;;/p-2 * **INCHI Key:** GFHNAMRJFCEERV-UHFFFAOYSA-L * **Molecular Weight:** 237.93 * **Canonical SMILES:** O.O.O.O.O.O.[Cl-].[Cl-].[Co+2] * **Isomeric SMILES:** N/A * **Molecular Formula:** Cl2CoH12O6 {{:chemogenomics:structures:chem-0204.svg?nolink}} * **Supplier Name:** Sigma-Aldrich * **Catalog #:** 255599 * **Lot #:** 04324JB * **XRPD:** Expected CoCl2 6H2O; found CoCl2 2H2O ===ABT-702+CoCl2=== * **Platform ID:** ABT-702_5uM_CoCL2 * **Min:** -17.8504; **Max:** 94.9567 {{:chemogenomics:dose_response:dr_479.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |18.9608 | | IC30 |21.8407 | | IC40 |24.9641 | | IC50 |28.5698 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ \\ \\ The dose response curve for ABT-702 is also available at: * [[results:exp318|exp318]] * [[results:exp260|exp260]] * [[results:exp261|exp261]] The dose response curve for CoCl2 is also available at: * [[results:exp346|exp346]] ==== Screen Summary ==== * **Round**: 07 * **Dose**: 5µM + 18µM * **Days of incubation**: 8 * **Doublings**: 1.6 * **Numbers of reads**: 15474850 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |37/12|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/ABT-702_5uM_CoCl2_18uM_Round-7_exp320.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp320.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:S:SLC39A9|SLC39A9]]|-4.19|<0.01| |[[:human_genes:S:SLC30A1|SLC30A1]]|-3.95|<0.01| |[[:human_genes:S:SYVN1|SYVN1]]|-3.18|0.03| |[[:human_genes:S:SLC7A11|SLC7A11]]|-3.17|<0.01| |[[:human_genes:S:SLC39A10|SLC39A10]]|-3.02|<0.01| |[[:human_genes:P:POLE3|POLE3]]|-2.96|<0.01| |[[:human_genes:L:LEO1|LEO1]]|-2.91|<0.01| |[[:human_genes:E:EDF1|EDF1]]|-2.81|<0.01| |[[:human_genes:P:PSMB8|PSMB8]]|-2.81|<0.01| |[[:human_genes:G:GTPBP2|GTPBP2]]|-2.75|<0.01| |[[:human_genes:G:GLRX3|GLRX3]]|-2.70|0.01| |[[:human_genes:M:MGA|MGA]]|-2.66|0.01| |[[:human_genes:M:MBNL1|MBNL1]]|-2.63|0.01| |[[:human_genes:M:MAEA|MAEA]]|-2.62|0.01| |[[:human_genes:E:ETAA1|ETAA1]]|-2.60|0.02| |[[:human_genes:C:CYB561A3|CYB561A3]]|-2.59|0.03| |[[:human_genes:S:SH3GL1|SH3GL1]]|-2.57|0.05| |[[:human_genes:E:EIF4A1|EIF4A1]]|-2.57|0.03| |[[:human_genes:N:NCOA4|NCOA4]]|-2.51|0.02| |[[:human_genes:D:DERL2|DERL2]]|-2.49|0.02| |[[:human_genes:O:OR4D2|OR4D2]]|-2.45|0.04| |[[:human_genes:O:OTUB1|OTUB1]]|-2.45|0.04| |[[:human_genes:I:IGF1R|IGF1R]]|-2.44|0.07| |[[:human_genes:A:ATP6V0A2|ATP6V0A2]]|-2.42|0.05| |[[:human_genes:P:POLE4|POLE4]]|-2.42|0.03| |[[:human_genes:K:KPNA3|KPNA3]]|-2.41|0.05| |[[:human_genes:C:CISD3|CISD3]]|-2.41|0.03| |[[:human_genes:H:HEXIM1|HEXIM1]]|-2.39|0.03| |[[:human_genes:I:IWS1|IWS1]]|-2.36|0.04| |[[:human_genes:A:ALDH4A1|ALDH4A1]]|-2.36|0.04| |[[:human_genes:S:STT3B|STT3B]]|2.23|0.09| |[[:human_genes:O:OR9K2|OR9K2]]|2.23|0.14| |[[:human_genes:G:GANAB|GANAB]]|2.23|0.19| |[[:human_genes:B:BACH2|BACH2]]|2.26|0.13| |[[:human_genes:S:SUPT5H|SUPT5H]]|2.27|0.22| |[[:human_genes:Z:ZNF681|ZNF681]]|2.31|0.21| |[[:human_genes:E:EIF1|EIF1]]|2.32|0.21| |[[:human_genes:T:TRMT61A|TRMT61A]]|2.33|0.16| |[[:human_genes:E:EMC8|EMC8]]|2.35|0.06| |[[:human_genes:X:XAB2|XAB2]]|2.38|0.41| |[[:human_genes:S:SLC39A14|SLC39A14]]|2.39|0.05| |[[:human_genes:B:BCL11A|BCL11A]]|2.39|0.05| |[[:human_genes:T:TTC7A|TTC7A]]|2.40|0.05| |[[:human_genes:F:FAM98B|FAM98B]]|2.44|0.04| |[[:human_genes:K:KEAP1|KEAP1]]|2.46|0.06| |[[:human_genes:M:METTL1|METTL1]]|2.46|0.11| |[[:human_genes:C:CABP4|CABP4]]|2.52|0.04| |[[:human_genes:E:EIF2S3|EIF2S3]]|2.54|0.09| |[[:human_genes:S:STRADA|STRADA]]|2.62|0.04| |[[:human_genes:M:MOGS|MOGS]]|2.68|0.04| |[[:human_genes:K:KLF16|KLF16]]|2.68|0.05| |[[:human_genes:P:PRKAG1|PRKAG1]]|2.74|0.01| |[[:human_genes:P:PRKAA1|PRKAA1]]|2.82|<0.01| |[[:human_genes:P:PYROXD1|PYROXD1]]|2.84|0.06| |[[:human_genes:S:SLFN11|SLFN11]]|2.97|<0.01| |[[:human_genes:T:TMEM165|TMEM165]]|3.11|<0.01| |[[:human_genes:B:BCL2L15|BCL2L15]]|3.16|<0.01| |[[:human_genes:S:SEC31A|SEC31A]]|3.22|<0.01| |[[:human_genes:M:MAT2B|MAT2B]]|3.63|<0.01| |[[:human_genes:S:SLC39A8|SLC39A8]]|8.50|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp346|CoCl2 18μM R07 exp346]]|0.181|| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|0.083|| {{:chemogenomics:comparison_plots:exp320_vs_exp346.png?nolink |}} {{:chemogenomics:comparison_plots:exp320_vs_exp321.png?nolink |}} ^GO Term^Fold Change^Genes^ |epsilon DNA polymerase complex|285.84|POLE3,POLE4| |Hrd1p ubiquitin ligase ERAD-L complex|228.68|SYVN1,DERL2| |zinc ion transmembrane transporter activity|74.57|SLC39A9,SLC30A1,SLC39A10| |intracellular zinc ion homeostasis|71.46|SLC39A9,SLC30A1,SLC39A10| |zinc ion transmembrane transport|65.96|SLC39A9,SLC30A1,SLC39A10| |zinc ion transport|63.52|SLC39A9,SLC30A1,SLC39A10| |intracellular iron ion homeostasis|33.63|GLRX3,CYB561A3,NCOA4,ATP6V0A2| |intracellular monoatomic cation homeostasis|9.91|SLC39A9,SLC30A1,SLC39A10,GLRX3,CYB561A3,NCOA4,ATP6V0A2| |inorganic ion homeostasis|9.71|SLC39A9,SLC30A1,SLC39A10,GLRX3,CYB561A3,NCOA4,ATP6V0A2| |intracellular chemical homeostasis|9.69|SLC39A9,SLC30A1,SLC7A11,SLC39A10,GLRX3,CYB561A3,NCOA4,IGF1R,ATP6V0A2| |intracellular monoatomic ion homeostasis|9.69|SLC39A9,SLC30A1,SLC39A10,GLRX3,CYB561A3,NCOA4,ATP6V0A2| |monoatomic cation homeostasis|8.39|SLC39A9,SLC30A1,SLC39A10,GLRX3,CYB561A3,NCOA4,ATP6V0A2| |monoatomic ion homeostasis|8.23|SLC39A9,SLC30A1,SLC39A10,GLRX3,CYB561A3,NCOA4,ATP6V0A2| |cellular homeostasis|8.06|SLC39A9,SLC30A1,SLC7A11,SLC39A10,GLRX3,CYB561A3,NCOA4,IGF1R,ATP6V0A2| |chemical homeostasis|6.15|SLC39A9,SLC30A1,SLC7A11,SLC39A10,GLRX3,CYB561A3,NCOA4,IGF1R,ATP6V0A2| ^GO Term^Fold Change^Genes^ |manganese ion transport|165.79|SLC39A8,TMEM165,SLC39A14|